Published in Neurosci Lett on December 31, 2011
BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 0.86
IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. PLoS One (2014) 0.85
Early life nutrient restriction impairs blood-brain metabolic profile and neurobehavior predisposing to Alzheimer's disease with aging. Brain Res (2012) 0.81
The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice. Neurobiol Aging (2016) 0.75
Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease. PLoS One (2016) 0.75
Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders. Neurochem Res (2016) 0.75
Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci (2001) 2.85
Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med (2002) 2.13
Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci (2000) 2.11
Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci (2001) 1.99
Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci U S A (2004) 1.75
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes (2001) 1.59
Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (1996) 1.50
Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry (2007) 1.25
Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol Aging (2005) 1.20
Long-term trends in blood lead levels among children in Chicago: relationship to air lead levels. Pediatrics (1994) 1.15
The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons. Eur J Neurosci (1999) 1.14
Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor. J Biol Chem (2001) 1.14
Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis (2000) 1.12
Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum (2001) 1.09
Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem (2000) 1.05
Altered dendritic development of cerebellar Purkinje cells in slice cultures from protein kinase Cgamma-deficient mice. Neuroscience (2002) 1.04
Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol (1997) 0.98
Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death. Proc Natl Acad Sci U S A (2001) 0.98
A role for cholesterol as a structural effector of the nicotinic acetylcholine receptor. Biochemistry (1994) 0.97
Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci U S A (1998) 0.96
IGF-I and the aging mammalian brain. Exp Gerontol (2010) 0.95
Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm IGF Res (2007) 0.93
Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res (1992) 0.92
Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc (2007) 0.91
Cryopreservation of human brain tissue. Exp Neurol (1990) 0.90
Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation. Neuroscience (1996) 0.90
Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. Biomaterials (2004) 0.90
Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro. Eur J Neurosci (2004) 0.89
Insulin-like growth factor I treatment for cerebellar ataxia: addressing a common pathway in the pathological cascade? Brain Res Brain Res Rev (2005) 0.89
Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway. Eur J Neurosci (1999) 0.89
Corticotropin releasing factor (CRF): immunocytochemical localization and radioimmunoassay (RIA). Life Sci (1982) 0.89
Astrocytic shape and glial fibrillary acidic protein immunoreactivity are modified by estradiol in primary rat hypothalamic cultures. Brain Res Dev Brain Res (1989) 0.88
Phospholipid interactions of a peptide from the fusion-related domain of the glycoprotein of VHSV, a fish rhabdovirus. Virology (1998) 0.88
Role of astroglia and insulin-like growth factor-I in gonadal hormone-dependent synaptic plasticity. Brain Res Bull (1997) 0.88
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders. Growth Horm IGF Res (2011) 0.87
Hepatic mRNA expression of acid labile subunit and deiodinase 1 differs between cows selected for high versus low concentrations of insulin-like growth factor 1 in late pregnancy. J Dairy Sci (2013) 0.87
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice. Transl Psychiatry (2013) 0.87
Endocrine-dependent accumulation of IGF-I by hypothalamic glia. Neuroreport (1996) 0.87
Basic fibroblast growth factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology (1992) 0.86
Protein structural effects of agonist binding to the nicotinic acetylcholine receptor. FEBS Lett (1992) 0.86
[Manual labor and Dupuytren disease. The results of a computerized survey in the field of iron metallurgy]. Ann Chir Main (1983) 0.85
Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol Cell Neurosci (2003) 0.85
Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology. Mol Psychiatry (2011) 0.85
Estrogen receptors and insulin-like growth factor-I receptors mediate estrogen-dependent synaptic plasticity. Neuroreport (2000) 0.84
Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A (1985) 0.84
Involvement of protein kinase C and nitric oxide in the modulation by insulin-like growth factor-I of glutamate-induced GABA release in the cerebellum. Neuroscience (1996) 0.84
Learning of the conditioned eye-blink response is impaired by an antisense insulin-like growth factor I oligonucleotide. Proc Natl Acad Sci U S A (1994) 0.84
Orthograde transport and release of insulin-like growth factor I from the inferior olive to the cerebellum. J Neurosci Res (1993) 0.84
Gonadal steroids as promoters of neuro-glial plasticity. Psychoneuroendocrinology (1994) 0.83
Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias? J Neural Transm (Vienna) (2007) 0.82
Role of cholesterol as a structural and functional effector of the nicotinic acetylcholine receptor. Biochem Soc Trans (1994) 0.82
Long-term depression of glutamate-induced gamma-aminobutyric acid release in cerebellum by insulin-like growth factor I. Proc Natl Acad Sci U S A (1993) 0.82
Purkinje cell dendritic tree development in the absence of excitatory neurotransmission and of brain-derived neurotrophic factor in organotypic slice cultures. Neuroscience (2004) 0.82
Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10. Br J Pharmacol (1997) 0.81
Insulin-like growth factor I modulates c-Fos induction and astrocytosis in response to neurotoxic insult. Neuroscience (1997) 0.81
Calorie restriction and resveratrol supplementation prevent age-related DNA and RNA oxidative damage in a non-human primate. Exp Gerontol (2013) 0.81
Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin. Proc Natl Acad Sci U S A (1983) 0.81
Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome. J Obstet Gynaecol Res (2000) 0.81
Ontogeny of insulin-like growth factor I, its receptor, and its binding proteins in the rat hypothalamus. Brain Res Dev Brain Res (1991) 0.81
[Bevacizumab and lung cancer: eligible patients in daily practice]. Rev Mal Respir (2011) 0.81
Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway. Neuroreport (2001) 0.80
Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes. Br J Pharmacol (1998) 0.80
Modeling, mutagenesis, and structural studies on the fully conserved phosphate-binding loop (loop 8) of triosephosphate isomerase: toward a new substrate specificity. Proteins (2001) 0.80
Interaction between ion channel-inactivating peptides and anionic phospholipid vesicles as model targets. Biophys J (1996) 0.80
Synthesis and biological properties of ovine corticotropin-releasing factor (CRF). Life Sci (1982) 0.80
Estradiol modulates insulin-like growth factor I receptors and binding proteins in neurons from the hypothalamus. J Neuroendocrinol (1993) 0.79
Insulin-like growth factor I is an afferent trophic signal that modulates calbindin-28kD in adult Purkinje cells. J Neurosci Res (1995) 0.79
The effects of estradiol on the growth patterns of estrogen receptor-positive hypothalamic cell lines. Endocrinology (1990) 0.79
Estradiol promotion of changes in the morphology of astroglia growing in culture depends on the expression of polysialic acid of neural membranes. Glia (1995) 0.79
Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy. Neuroscience (2009) 0.78
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies. Cancer Res (2001) 0.78
Vagus nerve somatosensory evoked potentials in Parkinson's disease. J Neurol (2011) 0.77
Interaction of the signalling pathways of insulin-like growth factor-I and sex steroids in the neuroendocrine hypothalamus. Horm Res (1996) 0.77
Chronic intraventricular infusion of glial cell line-derived neurotrophic factor (GDNF) rescues some cerebellar Purkinje cells from heredodegeneration. Exp Neurol (2001) 0.77
D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men. J Clin Endocrinol Metab (1987) 0.77
Effect of [D-Trp6]LHRH infusion on prolactin secretion by perifused rat pituitary cells. Regul Pept (1987) 0.75
Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts. Clin Exp Immunol (1988) 0.75
Morphological study of organotypic cerebellar cultures. Acta Biol Hung (2002) 0.75
Radioimmunoassay of CRF-like material in rat plasma: validation of the method. Proc Soc Exp Biol Med (1983) 0.75
[The new G-DRG case reimbursement system. First adjustment of ENT case groups to the German cost structure]. HNO (2003) 0.75
Axonal and non-axonal immunolocalization of cytosolic aspartate aminotransferase (cAATase), GABA and glutamic acid decarboxylase (GAD) in the rat cochlear nucleus. J Hirnforsch (1992) 0.75
[Intraoperative diagnosis of the heart and great vessels--echocardiography]. Z Kardiol (1990) 0.75
Specific alterations of the insulin-like growth factor I system in the cerebellum of diabetic rats. Endocrinology (1996) 0.75
Lipoprotein (a) levels in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int (1996) 0.75
[The G-DRG system 2004 and its interfaces with the outpatient sector. Is the ENT medicine at the beginning of a structural change?]. HNO (2004) 0.75
Antiserum to LH-RH blocks haloperidol-induced hyperprolactinemia in female rats. Neuroendocrinology (1985) 0.75
Stimulation of insulin secretion by corticotropin-releasing factor (CRF) in anesthetized rats. Peptides (1984) 0.75
Synthesis and biological activity of a cyclic pseudohexapeptide analog of somatostatin. Biochem Biophys Res Commun (1984) 0.75
Mechanical and excitotoxic lesion of motoneurons: effects of neurotrophins and ciliary neurotrophic factor on survival and regeneration. Acta Neurochir Suppl (1999) 0.75
Chemical heterogeneity in adult rat cerebellar Purkinje cells as revealed by zebrin I and low-affinity nerve growth factor receptor immunocytochemical expression following injury. J Neurocytol (1995) 0.75
Effect of an antagonistic analog of LH-RH on haloperidol-induced hyperprolactinemia in female rats. Peptides (1986) 0.75
[Standardized findings in echocardiography using WWW: EchoBefundSystem]. Z Kardiol (2001) 0.75
Growth factors and the developmental neurobiology of the hypothalamus. Acta Paediatr Scand Suppl (1990) 0.75